Sequence Similarity Clusters for the Entities in PDB 1MFB

Entity #1 | Chains: L
IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) protein, length: 215 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 20993
95 % 2 39 540 Flexibility: Low
Max RMSD: 8.9, Avg RMSD: 2.4
PDBFlex
90 % 3 45 490
70 % 525 2637 1
50 % 1085 5362 1
40 % 1298 6051 1
30 % 1583 7514 1
Entity #2 | Chains: H
IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) protein, length: 219 (BLAST)
Sequence Similarity Cutoff Rank Chains in Cluster Cluster ID / Name Structural variation in cluster
100 % 1 4 21299
95 % 1 4 19270 Flexibility: No
Max RMSD: 0.5, Avg RMSD: 0.3
PDBFlex
90 % 2 11 4480
70 % 528 2600 2
50 % 1086 5362 1
40 % 1299 6051 1
30 % 1584 7514 1

Instructions

In the table for each entity, view a list of similar sequences by selecting the link associated with the percentage cutoff.



View more detailed documentation on the redundancy reduction and sequence clustering procedure used by RCSB PDB.

You can also use the structure comparison tool to compare any 2 given structures


ACTION - (A) Select for download / view details OR (B) Select two chains for comparison
Rank PDB ID Entity ID Chains Description Details Taxonomy EC Number
1 4UNU 1 A, B IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
2 3PUC 1 A Titin domain M7 (UNP RESIDUES 33774-33871) 9606 2.7.11.1 | Details
3 1U2H 1 A Aortic preferentially expressed protein 1 residues 15-113 9606
4 5IVN 1 A BC2-nanobody 30538
5 5ACM 1 A, B MCG IG LAMBDA CHAIN V-II REGION MGC 9606
6 5E7B 1 A nanobody nano-L06 9838
7 2P45 2 B ANTIBODY CAB-RN05 9838
8 2X1Q 1 A, B GELSOLIN NANOBODY 9844
9 5U64 1 B VHH-28 9838
10 6APO 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
11 2X1P 1 A, B, C, D GELSOLIN NANOBODY 9844
12 4B41 1 A, B ANTIBODY G7 9844
13 2JJU 1 A, B SIGNAL REGULATORY PROTEIN BETA-1 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
14 4NZU 1 L 13PL heavy chain Fab 9606
15 4NZU 2 H 13PL light chain Fab 9606
16 1MJU 1 L IMMUNOGLOBULIN MS6-12 Fab fragment, LIGHT CHAIN 10090
17 1MJU 2 H IMMUNOGLOBULIN MS6-12 Fab fragment, HEAVY CHAIN 10090
18 5TZM 1 A Obscurin UNP residues 4946-5036 9606 2.7.11.1 | Details
19 5IMM 1 B Nanobody 9835
20 4QYO 1 A Fv fragment(mAb6D8) heavy chain 10090
21 4QYO 2 B Fv fragment(mAb6D8) light chain 10090
22 5NLU 1 A single domain llama antibody Nb36 9844
23 2Q20 1 A, B Vk1 O18/O8 germline light chain variable domain 9606
24 4TRP 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
25 4TRP 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
26 1MEX 1 L Fab 29G12 light chain 10090
27 1MEX 2 H Fab 29G12 heavy chain 10090
28 1MQK 1 L antibody 7E2 FV fragment, light chain 10090
29 1MQK 2 H antibody 7E2 FV fragment, heavy chain 10090
30 5IMK 1 B Nanobody 9835
31 3D9A 2 L Light Chain of HyHel10 Antibody Fragment (Fab) 10090
32 3D9A 3 H Heavy Chain of HyHel10 Antibody Fragment (Fab) 10090
33 6EH4 1 D Human T Cell Receptor Alpha Chain 9606
34 6EH4 2 E Human T Cell Receptor Beta Chain 9606
35 3TPK 1 A Immunoglobulin heavy chain antibody variable domain KW1 9835
36 4BUH 1 A, B CLONE M0418 SCFV 9606
37 4B50 1 A 2H10 LLAMA VHH 9844
38 3TV3 1 L PGT128 light chain, Ig lambda-2 chain C regions PGT128 light chain 9606
39 3TV3 2 H PGT128 heavy chain, Ig gamma-1 chain C region PGT128 heavy chain 9606
40 6FR4 1 A TCR 003 alpha chain 9606
41 6FR4 2 B TCR 003 Beta Chain 9606
42 1NCW 1 L IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, light chain 10090
43 1NCW 2 H IMMUNOGLOBULIN IGG2A Antibody FAB fragment 4C6, heavy chain 10090
44 6DBA 1 A, B nanobody VHH R303 9838
45 6EH5 1 A Human T Cell Receptor Alpha Chain 9606
46 6EH5 2 B Human T Cell Receptor Beta Chain 9606
47 5YD4 1 A, C, E, G scFv 4B08 10090
48 5YD3 1 A, C, E, G scFv 4B08 10090
49 2XT1 2 B CAMELID VHH 9 30538
50 5UD9 1 H Fab heavy chain 9606
51 5UD9 2 L Light chain 9606
52 4QY8 1 A Fv fragment(mAb6D8) heavy chain 10090
53 4QY8 2 B Fv fragment(mAb6D8) light chain 10090
54 4P48 1 A Antibody scFv 180 9031
55 4UDT 1 A T CELL RECEPTOR ALPHA CHAIN, T-CELL RECEPTOR ALPHA CHAIN C REGION VARIABLE DOMAIN TRAV22, RESIDUES 1-112, CONSTANT DOMAIN TRAC1, RESIDUES 2-95 9606
56 4UDT 2 B PROTEIN TRBV7-9, T-CELL RECEPTOR BETA-2 CHAIN C REGION VARIABLE DOMAIN TRBV7-9, RESIDUES 20-115, CONSTANT DOMAIN TRBC2, RESIDUES 1-129 9606
57 5VLV 1 A Single Domain Camelid Nanobody VHH T9 9844
58 5TY6 1 H VRC 315 13-1b02 Fab Heavy chain 9606
59 5TY6 2 L VRC 315 13-1b02 Fab Light chain 9606
60 6FR3 1 A 003 TCR Alpha Chain 9606
61 6FR3 2 B 003 TCR Beta Chain 9606
62 2XZC 1 H FAB A.17 HEAVY CHAIN 9606
63 2XZC 2 L FAB A.17 LIGHT CHAIN 9606
64 5J1S 3 C VHH domain BS-2 30538
65 2XKN 1 A, C ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT LIGHT CHAIN (IGG1), RESIDUES 1-223 10090
66 2XKN 2 B, D ANTI-EGFR ANTIBODY 7A7 FAB FRAGMENT HEAVY CHAIN (IGG1), RESIDUES 1-216 10090
67 2P49 2 B ANTIBODY CAB-RN05 TRUNCATED AT RESIDUE 121 9838
68 2I24 1 N New Antigen Receptor PBLA8 variable domain 7801
69 5L6Q 1 A, B H5AL 9606
70 5J1T 3 C VHH domain BS-2 30538
71 5KVG 2 L ZV-67 Antibody Fab Light Chain 10090
72 5KVG 3 H ZV-67 Antibody Fab Heavy Chain 10090
73 5WCA 1 H VRC315 27-1C08 Fab Heavy chain 9606
74 5WCA 2 L VRC315 27-1C08 Fab Light chain 9606
75 6FR5 1 A TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, alpha chain 9606
76 6FR5 2 B TCR HA1.7 specific for FLU epitope PKYVKQNTLKLAT, beta chain 9606
77 4XCF 1 L 4E10 Fab light chain 9606
78 4XCF 2 H 4E10 Fab heavy chain 9606
79 5M13 2 B synthetic Nanobody L2_C06 (a-MBP#2) 32630
80 5KVF 2 L ZV-64 Antibody Fab Light Chain 10090
81 5KVF 3 H ZV-64 Antibody Fab Heavy Chain 10090
82 1RUP 1 L immunoglobulin igg2a, heavy chain fab 10090
83 1RUP 2 H immunoglobulin igg2a, light chain fab 10090
84 3ESU 1 F Antibody 14b7* light chain and antibody 14b7* heavy chain linked with a synthetic (GGGGS)4 linker 10090
85 3KNB 1 A Titin titin, C-terminal domain M10, resideus 34253-34350 9606 2.7.11.1 | Details
86 3KNB 2 B Obscurin-like protein 1 obscurin-like 1, N-terminal domain, residues 1-105 9606
87 1RUK 1 L immunoglobulin igg2a, light chain fab 10090
88 1RUK 2 H immunoglobulin igg2a, heavy chain fab 10090
89 5VXR 1 H MAb24 Variable Heavy Chain,MAb24 Variable Heavy Chain 10090
90 5VXR 2 L MAb24 Variable Light Chain,MAb24 Variable Light Chain 10090
91 5X08 1 H Fab 4E10 Heavy chain 9606
92 5X08 2 L Fab 4E10 Light chain 9606
93 2YZ1 1 A, B Tyrosine-protein phosphatase non-receptor type substrate 1 ligand-binidng domain, Ig-like V-type domain 10090
94 2X1O 1 A, B GELSOLIN NANOBODY 9844
95 4QGY 1 A, B nanobody n25, VH domain 9844
96 5C2B 1 H scFv 3B4 heavy chain 9606
97 5C2B 2 L 3B4 light chain 9606
98 4WW1 1 A TCR Alpha Chain-TRAV21-TRAJ8 9606
99 4WW1 2 B TCR Beta Chain-TRBV7-8 9606
100 4XAW 1 L 4E10 Fab light chain 9606
101 4XAW 2 H 4E10 Fab heavy chain 9606
102 5VNV 1 A Nb.b201 32630
103 4P49 1 A Antibody scFv B8 9031
104 3N9G 1 H Fab fragment of MAb CR4354, heavy chain 9606
105 3N9G 2 L Fab fragment of MAb CR4354, light chain 9606
106 4TUL 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
107 4TUL 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
108 5DXW 1 A PD-L1 nanobody 10090
109 2NW2 1 A ELS4 TCR alpha chain 9606
110 2NW2 2 B ELS4 TCR beta chain 9606
111 5UCB 1 H Fab Heavy Chain 9606
112 5UCB 2 L Fab Light Chain 9606
113 3T0W 1 A, B immunoglobulin variable lambda domain 9606
114 2VXV 1 H HUMAN IGG ABT-325 9606
115 2VXV 2 L HUMAN IGG ABT-325 9606
116 4N9O 2 B Nanobody Nb484 Nb484 9844
117 4M3K 2 B Camelid heavy-chain antibody variable fragment cAb-H7S 9844
118 5ACL 1 A MCG IG LAMBDA CHAIN V-II REGION MGC 9606
119 3T0V 1 A immunoglobulin variable lambda domain 9606
120 4GXV 1 H, I Antibody 1F1, heavy chain 9606
121 4GXV 2 L, M Antibody 1F1, light chain 9606
122 6AT6 1 B T-cell receptor beta variable 28, Human nkt tcr beta chain chimera 9606
123 6AT6 2 A T-cell receptor alpha variable 4, T-cell receptor, sp3.4 alpha chain chimera 9606
124 2VXT 1 H MURINE IGG 125-2H 10090
125 2VXT 3 L MURINE IGG 125-2H 10090
126 1OAQ 1 H HEAVY CHAIN FV, RESIDUES 1-121 10090
127 1OAQ 2 L LIGHT CHAIN FV, RESIDUES 1-120 10090
128 1T2J 1 A M12-Variable Heavy domain 9606
129 1DLF 1 L ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
130 1DLF 2 H ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) FV FRAGMENT (VH AND VL DOMAINS) 10090
131 6DBF 2 B InlB specific VHH R303 9838
132 6CR1 1 L Light chain of adalimumab EFab (VL-IgE CH2) 9606
133 6CR1 2 H Heavy chain of adalimumab EFab (VH-IgE CH2) 9606
134 6DBG 2 C, D VHH R303 9838
135 1RUM 1 L immunoglobulin igg2a, light chain fab 10090
136 1RUM 2 H immunoglobulin igg2a, heavy chain fab 10090
137 2XA3 1 A LLAMA HEAVY CHAIN ANTIBODY D7 VARIABLE DOMAIN OF A HEAVY CHAIN ANTIBODY 9844
138 2XZA 1 H FAB A.17 HEAVY CHAIN 9606
139 2XZA 2 L FAB A.17 LIGHT CHAIN 9606
140 2WP3 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
141 2WP3 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
142 1OGA 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
143 1OGA 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
144 2W60 1 A ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
145 2W60 2 B ANTI-CITRULLINATED COLLAGEN TYPE II FAB ACC4 10090
146 5W24 1 L 5C4 Fab Light Chain 10090
147 5W24 2 H 5C4 Fab Heavy Chain 10090
148 4HPY 1 H CH59 Fab heavy chain 9606
149 4HPY 2 L CH59 Fab light chain 9606
150 3T65 1 B S25-2 FAB (IGG1K) heavy chain 10090
151 3T65 2 A S25-2 FAB (IGG1K) light chain 10090
152 5C6W 1 H, J Protein IGHV1-69-2,Ig lambda chain V-II region NIG-84 9606
153 5VM6 1 A single domain camelid nanobody VHH T10 9844
154 1RJC 1 A camelid heavy chain antibody VHH DOMAIN, VARIABLE DOMAIN 9838
155 4JG1 1 L Fab light chain 9606
156 4JG1 2 H Fab heavy chain 9606
157 1SQ2 2 N novel antigen receptor 7801
158 3M8O 1 L IMMUNOGLOBULIN A1 LIGHT CHAIN Fab fragment 9606
159 3M8O 2 H IMMUNOGLOBULIN A1 HEAVY CHAIN Fab fragment 9606
160 4KML 2 B Nanobody 9844
161 5VF2 1 A scFv 2D10 10090
162 5I8C 1 A VRC34.01 Fab heavy chain 9606
163 5I8C 2 B VRC34.01 Fab light chain 9606
164 4O5L 1 L Fab F045-092 light chain 9606
165 4O5L 2 H Fab F045-092 heavy chain 9606
166 5MYX 1 A, C Fab c#24 light chain 10090
167 5MYX 2 B, D Fab c#24 heavy chain Pyroglutamate residue 1 (PCA) results from post-translational modification of original residue glutamine 1. 10090
168 4Z9K 2 B VHH2(F5) antibody 30538
169 3IFL 1 L 12A11 FAB antibody light chain 10090
170 3IFL 2 H 12A11 FAB antibody heavy chain 10090
171 5WK2 1 L M116 LIGHT CHAIN 9606
172 5WK2 2 H M116 HEAVY CHAIN FD 9606
173 3PP4 1 H GA101 Fab heavy chain 10090
174 3PP4 2 L GA101 Fab light chain 10090
175 3KDM 1 A, L Immunoglobulin light chain 9606
176 3KDM 2 B, H Immunoglobulin heavy chain 9606
177 5NIV 1 A Light chain of 5D3 Fab 10090
178 5NIV 2 B Heavy chain of 5D3 Fab 10090
179 5N4J 1 L LIGHT CHAIN 9606
180 5N4J 2 H HEAVY CHAIN the sequence provided include the cleavable tag 9606
181 2AJU 1 L ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
182 2AJU 2 H ANTIBODY 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
183 2AJV 1 L Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 KAPPA LIGHT CHAIN 10090
184 2AJV 2 H Antibody 7A1 Fab' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
185 5X4G 1 A 6H8 Fab heavy chain 10090
186 5X4G 2 B 6H8 Fab light chain 10090
187 3SY0 1 A S25-2 FAB (IGG1K) light chain 10090
188 3SY0 2 B S25-2 FAB (IGG1K) heavy chain 10090
189 1J05 1 A, L anti-CEA mAb T84.66, light chain Fv fragment 10090
190 1J05 2 B, H anti-CEA mAb T84.66, heavy chain Fv fragment 10090
191 4PTU 1 A Antibody pn132p2C05, light chain 9606
192 4PTU 2 B Antibody pn132p2C05, heavy chain 9606
193 4TPR 1 L If kappa light chain 10090
194 4TPR 2 H Fab heavy chain 10090
195 5LMW 1 A Nanobody 9844
196 4HS6 2 A, L MRCT10.v362 Fab light chain 9606
197 4HS6 3 B, H MRCT10.v362 Fab heavy chain 9606
198 3IFN 1 H 12A11 FAB antibody heavy chain 10090
199 3IFN 2 L 12A11 FAB antibody light chain 10090
200 5U3P 1 H DH511.4 Fab Heavy Chain 9606
201 5U3P 2 L DH511.4 Fab Light Chain 9606
202 6BLA 1 H AMM01 Fab Heavy chain 9606
203 6BLA 2 L AMM01 Fab Light chain 9606
204 5NM0 1 A, B, C, D Nb36 9844
205 4TOY 1 H 35O22 Fab Heavy chain 9606
206 4TOY 2 L 35O22 Fab Light chain 9606
207 4TUO 1 A, C Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
208 4TUO 2 B, D Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
209 3NPS 2 B S4 FAB HEAVY CHAIN 9606
210 3NPS 3 C S4 FAB LIGHT CHAIN 9606
211 2RHE 1 A BENCE-JONES PROTEIN RHE (LIGHT CHAIN) 9606
212 5I4F 1 A scFv 2D10 10090
213 1RUR 1 L immunoglobulin 13G5, light chain fab 10090
214 1RUR 2 H immunoglobulin 13G5, heavy chain fab 10090
215 4QXT 1 A Fv fragment(mAb6D8) heavy chain 10090
216 4QXT 2 B Fv fragment(mAb6D8) light chain 10090
217 5VAA 1 A, B Ig gamma-2A chain C region, A allele UNP residues 107-330 10090
218 5ADO 1 H FAB A.17 HEAVY CHAIN 9606
219 5ADO 2 L FAB A.17 LIGHT CHAIN 9606
220 5WN9 1 H scFv 2D10 9606
221 4WEM 2 B Anti-F4+ETEC bacteria VHH variable region 9844
222 4XC3 1 L 4E10 Fab light chain 9606
223 4XC3 2 H 4E10 Fab heavy chain 9606
224 1X9Q 1 A 4m5.3 anti-fluorescein single chain antibody fragment antibody binding fragment 9606
225 4PPT 1 A Engineered single domain VHH antibody 9844
226 3R0M 1 A, B Llama VHH A12 9844
227 4M5Y 1 H, I Fab 5J8 heavy chain 9606
228 4M5Y 2 L, M Fab 5J8 light chain 9606
229 4TQE 1 L If kappa light chain 10090
230 4TQE 2 H Fab heavy chain 10090
231 3ZKQ 2 D XA4813 9844
232 5YY4 1 A scFv 4B08 10090
233 4I13 2 B Protein ca1697 (nanobody) 9844
234 2BNU 1 A T-CELL RECEPTOR ALPHA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-91 9606
235 2BNU 2 B T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR DOMAINS, RESIDUES 1-130 9606
236 4ISV 1 A 1C2 FAB LIGHT CHAIN 10090
237 4ISV 2 B 1C2 FAB HEAVY CHAIN 10090
238 4XC1 1 L 4E10 FAB LIGHT CHAIN 9606
239 4XC1 2 H 4E10 FAB HEAVY CHAIN 9606
240 5C2U 1 B Nanobody Nanobody 9838
241 5VSI 1 H CH1/Ckappa Fab heavy chain 9606
242 5VSI 2 L CH1/Ckappa Fab light chain 9606
243 2YXM 1 A Myosin-binding protein C, slow-type I-set domain 9606
244 1XFP 1 A heavy chain antibody VHH domain 9838
245 5ODB 1 A D10 Fab fragment - heavy chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
246 5ODB 2 B D10 Fab fragment - light chain not modeled residues are not visible in the electron density map the Fab fragment was prepared from a antibody chimera containing the variable domains of the human D10 mAb and the constant domains of mouse IgG2a heavy chain and Ig-lambda light chain 9606
247 4CMH 2 B HEAVY CHAIN OF SAR650984-FAB FRAGMENT 10090
248 4CMH 3 C LIGHT CHAIN OF SAR650984-FAB FRAGMENT 10090
249 5JXA 1 H VRC03 Heavy chain 9606
250 5JXA 2 L VRC03 Light chain 9606
251 3QHZ 1 H, I Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
252 3QHZ 2 L, M Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
253 4POY 1 A VHH-metal 9844
254 1A2Y 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
255 1A2Y 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
256 5M2W 1 A, B Llama nanobody nb8 against TssK from T6SS 9844
257 5NLW 1 A nanobody Nb36 9844
258 3CDC 1 A, B Light Chain Amyloidogenic 9606
259 3CDF 1 A, B, C, D, E, F IMMUNOGLOBULIN LIGHT CHAIN 9606
260 3UJI 1 L Light chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
261 3UJI 2 H Fab region of the heavy chain of anti-HIV-1 V3 monoclonal antibody 2558 9606
262 3DVI 1 A Amyloidogenic light chain variable domain AL-103 9606
263 3NTC 1 L Fab light chain 10090
264 3NTC 2 H Fab heavy chain 10090
265 2DLF 1 L PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S)-KAPPA (LIGHT CHAIN)) FV FRAGMENT (VL DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
266 2DLF 2 H PROTEIN (ANTI-DANSYL IMMUNOGLOBULIN IGG2A(S) (HEAVY CHAIN)) FV FRAGMENT (VH DOMAIN) SYNONYM: ANTI-DANSYL FV FRAGMENT 10090
267 4YNY 1 A, C Heavy chain of antigen binding fragment, Fab 10116
268 4YNY 2 B, D Light chain of antigen binding fragment, Fab 10116
269 4TUK 1 H Heavy chain of monoclonal antibody against neuroblastoma associated antigen 10090
270 4TUK 2 L Light chain of monoclonal antibody against neuroblastoma associated antigen 10090
271 4YO0 1 A, C Heavy chain of antigen binding fragment, Fab 10116
272 4YO0 2 B, D Light chain of antigen binding fragment, Fab 10116
273 1ZVH 2 A Immunoglobulin heavy chain antibody variable domain D2-L24 9838
274 6AZM 1 A, C 580 germline antibody, light chain Fragment: Fab 9606
275 6AZM 2 B, D 580 germline antibody, heavy chain Fragment: Fab 9606
276 6BE3 1 H Fab (F598) Heavy Chain 9606
277 6BE3 2 L Fab (F598) Light Chain 9606
278 2X6M 1 A HEAVY CHAIN VARIABLE DOMAIN FROM DROMEDARY ENGINEERED FROM IMMUNISED DROMEDARY 9838
279 6FUN 1 A Huamn F11 T-Cell Receptor alpha chain 9606
280 6FUN 2 B Human F11 T-Cell Receptor beta chain 9606
281 3G9A 2 B Minimizer 9838
282 4NWU 1 H APE1551 Ab Fab heavy chain 9606
283 4NWU 2 L APE1551 Ab Fab light chain 9606
284 1EEQ 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
285 1KGC 1 D T-cell receptor alpha chain 9606
286 1KGC 2 E T-cell receptor beta chain 9606
287 3HC4 1 H IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
288 3HC4 2 L IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
289 6FRC 1 A Human T-Cell Receptor F11 alpha Chain 9606
290 6FRC 2 B Human T-Cell Receptor beta Chain 9606
291 5VZR 1 A, H G4 antibody heavy chain Fab fragment 10090
292 5VZR 2 B, L G4 antibody light chain Fab fragment 10090
293 2W9D 1 H ICSM 18-ANTI-PRP THERAPEUTIC FAB HEAVY CHAIN 10090
294 2W9D 2 L ICSM 18-ANTI-PRP THERAPEUTIC FAB LIGHT CHAIN 10090
295 5EWI 1 H VRC38.01 Heavy Chain 9606
296 5EWI 2 L VRC38.01 Light Chain 9606
297 5E2W 1 L AT8 LIGHT CHAIN 10090
298 5E2W 2 H AT8 HEAVY CHAIN 10090
299 5MYK 1 A Fab c#17 light chain 10090
300 5MYK 2 B Fab c#17 heavy chain 10090
301 6FUQ 1 A Human F11 T-Cell Receptor 9606
302 6FUQ 2 B Human F11 T-Cell Receptor beta chain 9606
303 4NZR 1 H PGT135 heavy chain Fab 9606
304 4NZR 2 L PGT135 light chain Fab 9606
305 5MYO 1 A, C Fab c#6 light chain 10090
306 5MYO 2 B, D Fab c#6 heavy chain 10090
307 4HBC 1 H Antigen Binding Fragment, Immunoglobulin IgG - Heavy Chain 9986
308 4HBC 2 L Antigen Binding Fragment, Immunoglobulin IgG - Light Chain 9986
309 4AEH 1 H FAB ANTIBODY, HEAVY CHAIN VARIABLE DOMAIN, RESIDUES 1-231 10090
310 4AEH 2 L FAB ANTIBODY, LIGHT CHAIN VARIABLE DOMAIN, RESIDUES 1-214 10090
311 3U79 1 A, B, C, D, E, F, G, H Amyloidogenic immunoglobulin light chain protein AL-103 Y32F Y96F, variable domain 9606
312 5UEL 1 H 354NC102 Fab Heavy Chain 9606
313 5UEL 2 L 354NC102 Fab Light Chain 9606
314 3UZQ 1 A anti-dengue Mab 4E11 Single chain variable fragment 10090
315 2V17 2 H MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
316 2V17 3 L MONOCLONAL ANTIBODY FAB FRAGMENT MN423 DISULPHIDE BRIDGE BETWEEN L214 AND H137 IS REDUCED 10090
317 2P43 2 B ANTIBODY CAB-RN05 9838
318 2QHL 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular 7998
319 4J6R 2 H HEAVY CHAIN OF ANTIBODY VRC23 9606
320 4J6R 3 L LIGHT CHAIN OF ANTIBODY VRC23 9606
321 5E2V 1 L AT8 LIGHT CHAIN 10090
322 5E2V 2 H AT8 HEAVY CHAIN 10090
323 4KRN 1 A Nanobody/VHH domain EgA1 9844
324 5SY8 1 H 10E8 FAB HEAVY CHAIN 9606
325 5SY8 2 L 10E8 FAB LIGHT CHAIN 9606
326 4GFT 2 B Nanobody 9844
327 4TVS 2 a, b VHH Domain BS-1 30538
328 4W6Y 2 B Nanobody NbFedF9 9844
329 5OCK 1 L Human ACPA E4 Fab fragment - Light chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
330 5OCK 2 H Human ACPA E4 Fab fragment - Heavy chain the N-terminal glutamine is posttranslationally modified to pyroglutamic acid 9606
331 6EZW 1 B VHH antibody BCD090-M2 9844
332 5DD1 1 H ANTI-HIV ANTIBODY DH570 FAB HEAVY CHAIN 9544
333 5DD1 2 L ANTI-HIV ANTIBODY DH570 FAB LIGHT CHAIN 9544
334 5JUE 1 L light chain of UIC2 Fab 10090
335 5JUE 2 H heavy chain of UIC2 Fab 10090
336 5CIN 1 H FAB 4E10 HEAVY CHAIN 9606
337 5CIN 2 L FAB 4E10 LIGHT CHAIN 9606
338 1UAC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
339 1UAC 2 H Ig VH,anti-lysozyme 10090
340 5A2J 1 H SCFV-SM3 CONTAINS BOTH H AND L CHAINS OF SCFV-SM3, CONNECTEDBY A LINKER. CHAIN L RESIDUES ARE NUMBERED FROM 1000. RESIDUES 6-115,20-129 10090
341 5JR1 1 H 10E8 heavy chain 9606
342 5JR1 2 L 10E8 mature light chain 9606
343 4HEM 2 E, F, G Anti-baseplate TP901-1 Llama vHH 02 9844
344 6CA7 1 L PCT64_13C light chain 9606
345 6CA7 2 H PCT64_13C heavy chain 9606
346 5VF6 1 A single chain variable fragment 9031
347 3CFB 1 A, L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
348 3CFB 2 B, H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
349 3WII 1 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
350 3WII 2 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
351 6FR9 1 A T-Cell Receptor F11 alpha chain 9606
352 6FR9 2 B T-Cell Receptor F11 beta chain 9606
353 5OB5 2 H fAb Heavy chain 9606
354 5OB5 3 L fAb Light chain 9606
355 3BKJ 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
356 3BKJ 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
357 5I66 1 A 8B6 antibody, heavy chain 10090
358 5I66 2 B 8B6 antibody, light chain 10090
359 4JAM 1 A, H ANTIGEN BINDING FRAGMENT OF HEAVY CHAIN of CH103 9606
360 4JAM 2 B, L ANTIGEN BINDING FRAGMENT OF LIGHT CHAIN of CH103 9606
361 6BZY 1 H 22D11 Heavy Chain 10090
362 6BZY 2 L 22D11 Light Chain 10090
363 3QQ9 1 C, L 101F LIGHT CHAIN 10090
364 3QQ9 2 D, H 101F HEAVY CHAIN 10090
365 5TKK 2 H mouse antibody vFP5.01 heavy chain 10090
366 5TKK 3 L mouse antibody vFP5.01 light chain 10090
367 5FGB 1 A, B Anti-HCV E2 Fab HC84-1 light chain 9606
368 5FGB 2 C, E Anti-HCV E2 Fab HC84-1 heavy chain 9606
369 4R3S 1 A FV FRAGMENT(MAB6D8) HEAVY CHAIN 10090
370 4R3S 2 B FV FRAGMENT(MAB6D8) LIGHT CHAIN 10090
371 5W6C 1 H UCA Fab heavy chain 9606
372 5W6C 2 L UCA Fab light chain 9606
373 5M14 2 C, D synthetic Nanobody L2_G11 (a-MBP#2) 32630
374 5I1K 1 L FAB LIGHT CHAIN 9606
375 5I1K 2 H FAB HEAVY CHAIN 9606
376 3OZ9 1 L Fab NC-1 kappa light chain 10090
377 3OZ9 2 H Fab NC-1 IgG2a heavy chain 10090
378 4JDV 1 A, H Fab heavy chain NIH45-46 Germ-line HEAVY CHAIN, IG GAMMA-1 CHAIN 9606
379 4JDV 2 B, L Fab light chain NIH45-46 Germ-line Light CHAIN, IG Kappa 9606
380 5V7U 1 L CBTAU-22.1 Fab light chain 9606
381 5V7U 2 H CBTAU-22.1 Fab heavy chain 9606
382 5UEA 1 A, H Fab Heavy Chain 9606
383 5UEA 3 B, L Fab Light Chain 9606
384 4AL8 2 H FAB 2H12 HEAVY CHAIN 9606
385 4AL8 3 L FAB 2H12 LIGHT CHAIN 9606
386 1YC7 1 A, B anti-VSG immunoglobulin heavy chain variable domain cAbAn33 cAbAn33 9838
387 1EEU 1 A, B KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
388 3G5Y 1 A 175 light chain 10090
389 3G5Y 2 B 175 heavy chain 10090
390 5O02 2 C Nanobody (VHH) Nano-4 30538
391 5NMV 1 L Fab light chain 10088
392 5NMV 2 H Fab heavy chain 10088
393 4N8C 1 H, I Heavy chain of monoclonal antibody 10090
394 4N8C 2 L, M Light chain of monoclonal antibody 10090
395 5AZ2 1 H anti-human epiregulin antibody 9E5 Fab heavy chain 10090
396 5AZ2 2 L anti-human epiregulin antibody 9E5 Fab light chain 10090
397 4UNV 1 A IG LAMBDA CHAIN V-II REGION MGC LIGHT-CHAIN VARIABLE DOMAIN, RESIDUES 1-110 9606
398 4HGW 1 A Antibody Fab fragment, light chain 10090
399 4HGW 2 B Antibody Fab fragment, heavy chain 10090
400 1NLB 1 L antibody 19D9D6 light chain 10090
401 1NLB 2 H antibody 19D9D6 heavy chain 10090
402 1KXQ 2 E, F, G, H antibody VHH fragment CABAMD9 9838
403 1C5C 1 L CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 103-214) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-102) IS FROM MURINE SOURCE FAB 10090
404 1C5C 2 H CHIMERIC DECARBOXYLASE ANTIBODY 21D8 THE CONSTANT DOMAIN (RESIDUES 109-230) IS FROM HUMAN SOURCE, AND THE VARIABLE DOMAIN (RESIDUES 1-108) IS FROM MURINE SOURCE FAB 10090
405 3VFG 1 L 3F8 Light Chain 10090
406 3VFG 2 H 3F8 Heavy Chain 10090
407 4X7F 2 C, D Nano-25 Nanobody 30538
408 5TDN 1 A, C anti-HER2 Fab Light Chain 9606
409 5TDN 2 B, D anti-HER2 Fab Heavy Chain 9606
410 3QRG 1 L Fab light chain 9606
411 3QRG 2 H Fab heavy chain Fd fragment 9606
412 4UT7 1 H BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV HEAVY CHAIN DOMAIN, RESIDUES 1-130 9606
413 4UT7 2 L BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11 SCFV LIGHT CHAIN DOMAIN, RESIDUES 1-147 9606
414 5M6A 1 A, B, C, D Bence-Jones light chain 9606
415 4LLY 2 B, D light chain Clambda 9606
416 4LGR 2 B Camelid nanobody (VHH3) 30538
417 4EBQ 1 H anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, heavy chain Fab 10090
418 4EBQ 2 L anti-Vaccinia D8L antigen monoclonal IgG2a antibody LA5, light chain 10090
419 5EZI 1 H Fab c12 heavy chain 9606
420 5EZI 2 L Fab c12 Light chain 9606
421 5U66 2 A IgG1 fc derived from CD4-fc fusion 9606
422 4K23 1 H anti-uPAR antibody, heavy chain 10090
423 4K23 2 L anti-uPAR antibody, light chain 10090
424 5J57 2 B VHH single chain antibody V5E1 30538
425 3NCJ 1 L Fab15 Mut8 light chain 9606
426 3NCJ 2 H Fab15 Mut8 heavy chain 9606
427 3UO1 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
428 3UO1 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
429 6BA5 1 A, C, E, G Variable domain of Light Chain, antibody R11 9606
430 6BA5 2 B, D, F, H Variable domain Heavy chain, antibody R11 9606
431 4M1G 1 L Murine IgG2a A27D7 Light chain Fab domain 10090
432 4M1G 2 H Murine IgG2a A27D7 Heavy chain Fab domain 10090
433 5W05 1 L M59 FAB LIGHT CHAIN 10090
434 5W05 2 H M59 FAB HEAVY CHAIN FD 10090
435 1MFA 1 L IGG1-LAMBDA SE155-4 FAB (LIGHT CHAIN) 10090
436 1MFA 2 H IGG1-LAMBDA SE155-4 FAB (HEAVY CHAIN) 10090
437 2IPU 1 K, L IgG2a Fab fragment Heavy Chain 10090
438 2IPU 2 G, H IgG2a Fab fragment Light Chain Kappa 10090
439 5OMM 2 C Nanobody (VHH) Nano-14 30538
440 5E03 1 A mouse CTLA-4 nanobody 10090
441 3HC3 1 H IMMUNOGLOBULIN IGG1 FAB, LIGHT CHAIN 9606
442 3HC3 2 L IMMUNOGLOBULIN IGG1 FAB, HEAVY CHAIN 9606
443 4M61 1 A, C Fab A52 light chain 10090
444 4M61 2 B, D Fab A52 heavy chain 10090
445 5YE3 1 B 2A7D9 VH CH1 chain 10090
446 5YE3 2 A 2A7D9 L chain 10090
447 5LZ0 1 A, B PorM nanobody 9844
448 3BKM 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
449 3BKM 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
450 1UM5 1 L Antibody 21H3 L chain 10090
451 1UM5 2 H Antibody 21H3 H chain 10090
452 1KXV 2 C, D CAMELID VHH DOMAIN CAB10 9838
453 3QHF 1 H Human monoclonal antibody del2D1, Fab Heavy Chain Fab Heavy Chain 9606
454 3QHF 2 L Human monoclonal antibody del2D1, Fab Light Chain Fab Light Chain 9606
455 4NWT 1 L APE1531 Ab Fab light chain 9606
456 4NWT 2 H APE1531 Ab Fab heavy chain 9606
457 6DBE 1 A, B nanobody VHH R303 9844
458 3WHX 1 A mAb Fab H fragment 10090
459 3WHX 2 B mAb Fab L fragment 10090
460 3NA9 1 L Fab15 light chain 9606
461 3NA9 2 H Fab15 heavy chain 9606
462 3BAE 1 L WO2 IgG2a Fab fragment Light Chain Kappa 10090
463 3BAE 2 H WO2 IgG2a Fab fragment Heavy Chain 10090
464 6FUO 1 A Human F11 T-Cell Receptor alpha chain 9606
465 6FUO 2 B Human F11 T-Cell Receptor 9606
466 1NGZ 1 A Germline Metal Chelatase Catalytic Antibody, Light chain germline Fab fragment 10090
467 1NGZ 2 B Germline Metal Chelatase Catalytic Antibody, Heavy chain germline Fab fragment 10090
468 4LRI 1 A, B MSL-109 Light Chain 9606
469 4LRI 2 C, P MSL-109 Heavy Chain 9606
470 2XXC 1 B CAMELID VHH 9 30538
471 4ZTP 1 L Light chain of Fab fragment of rabbit monoclonal antibody R53 9986
472 4ZTP 2 H Heavy chain of Fab fragment of rabbit monoclonal antibody R53 9986
473 4JN2 1 A, L anti dabigatran Fab 10090
474 4JN2 2 B, H anti dabigatran Fab 10090
475 4XBE 1 L 4E10 FAB LIGHT CHAIN 9606
476 4XBE 2 H 4E10 Fab heavy chain 9606
477 1MJ8 1 L IMMUNOGLOBULIN MS6-126 Fab Fragment, LIGHT CHAIN 10090
478 1MJ8 2 H IMMUNOGLOBULIN MS6-126 Fab Fragment, HEAVY CHAIN 10090
479 6BE2 1 H Fab (F598) Heavy Chain 9606
480 6BE2 2 L Fab (F598) Light Chain 9606
481 3QYC 1 A, B VH domain of IgG molecule 9606
482 4EI6 1 A, C Valpha1 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
483 4EI6 2 B, D Vbeta16 XV19 Type II Natural Killer T cell receptor (mouse variable domain, human constant domain) extracellular domain (SEE REMARK 999) 10090
484 4JFZ 1 L Fab light chain 9606
485 4JFZ 2 H Fab heavy chain 9606
486 6ARP 1 A, C Cetuximab mutant light chain,Uncharacterized protein 9606
487 6ARP 2 B, D Cetuximab mutant Fab heavy chain,Immunoglobulin gamma-1 heavy chain 9606
488 5VAK 2 B Nb914 Nanobody 9844
489 3WIF 1 A mAb Fab H fragment 10090
490 3WIF 2 B mAb Fab L fragment 10090
491 5U6A 1 A Light Chain 9606
492 5U6A 2 B Heavy Chain 9606
493 5KVD 2 L ZV-2 Antibody Fab Light Chain 10090
494 5KVD 3 H ZV-2 Antibody Fab Heavy Chain 10090
495 3MBX 1 L X836 LIGHT CHAIN 10090
496 3MBX 2 H X836 HEAVY CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN, FD fragment 10090
497 4OF6 1 A, B Protein SYG-1, isoform b D1, UNP residues 19-129 6239
498 3TWC 1 L PGT127 light chain, Ig lambda-2 chain C regions 9606
499 3TWC 2 H PGT127 heavy chain, Ig gamma-1 chain C region 9606
500 2XXM 2 B CAMELID VHH 9 30538
501 6APC 1 H Epididymis luminal protein 214 9606
502 6APC 2 L IGL@ protein 9606
503 6BJ8 3 D TCR 55 alpha chain 9606
504 6BJ8 4 H TCR 55 beta chain 9606
505 5IR3 1 A Ig lambda chain V-VI region AR 9606
506 3QXT 1 A, B Anti-Methotrexate CDR1-3 Graft VHH 9844
507 4HHA 1 A Fab KE5 Fab fragment KE5 9606
508 4HHA 2 B Antibody KE5 AD-2S1 eptiope 9606
509 4AJ0 1 A, B, C, D GERMINAL LINE LAMBDA 3 3RCW VARIANT VARIABLE DOMAIN VARIANT OF 3RJL2, RESIDUES 1-107 9606
510 5A2K 1 H IG LAMBDA-1 CHAIN V REGION S43 RESIDUES 6-115,20-129 10090
511 4RGO 2 H 14G8 heavy chain Fab 10090
512 4RGO 3 L 14G8 light chain Fab 10090
513 5N7B 1 H Ig heavy chain V-III region J606,Ig lambda-1 chain V region S43 Please follow the numbering described in the PDB entry 5A2K 10090
514 5GRY 1 A, G diabody 9606
515 5UEK 2 H Fab 12E Heavy Chain 9606
516 5UEK 3 L Fab 12E Light Chain 9606
517 3NAA 1 L Fab15 Mut5 light chain 9606
518 3NAA 2 H Fab15 Mut5 heavy chain 9606
519 6DBD 1 A, B, C, D nanobody VHH R326 9844
520 1Q0X 1 L Fab 9B1, light chain 10090
521 1Q0X 2 H Fab 9B1, heavy chain 10090
522 4R90 1 L Anti CD70 Llama glama Fab 27B3 Light chain 9844
523 4R90 2 H Anti CD70 Llama glama Fab 27B3 Heavy chain 9844
524 4XVT 2 H donor 45 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Heavy chain 9606
525 4XVT 3 L 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995) Light chain 9606
526 5JDS 1 B Nanobody 9835
527 4OB5 1 H 4E10 antibody germline precursor 7 heavy chain Fv 9606
528 4OB5 2 L 4E10 antibody germline precursor 7 light chain Fv 9606
529 5IK3 1 A, C 1E03 Fab fragment heavy chain 9606
530 5IK3 2 B, D 1E03 Fab fragment light chain 9606
531 5NPH 2 H Heavy chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
532 5NPH 3 L Light chain of Fab fragment derived from non-neutralizing antibody DAO5 10090
533 5XLI 1 a, b FabL 10090
534 5XLI 2 c, d FabH 10090
535 5IHZ 1 A, C, E, H 1E01 Fab fragment heavy chain 9606
536 5IHZ 2 B, D, F, L 1E01 Fab fragment light chain 9606
537 1BWW 1 A, B PROTEIN (IG KAPPA CHAIN V-I REGION REI) IMMUNOGLOBULIN KAPPA LIGHT CHAIN 9606
538 2R1X 1 A Fab, antibody fragment (IgG1k), light chain 10090
539 2R1X 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
540 5U3D 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
541 5U3D 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
542 4WUK 1 H CH65 heavy chain 9606
543 4WUK 2 L CH65 light chain 9606
544 5L8L 2 B New antigen receptor variable domain 168098
545 3MLY 1 L, M Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab light chain 9606
546 3MLY 2 H, I Human monoclonal anti-HIV-1 gp120 V3 antibody 3074 Fab heavy chain 9606
547 5U3O 1 H DH511.2_K3 Fab Heavy Chain 9606
548 5U3O 2 L DH511.2_K3 Fab Light Chain 9606
549 1ZVY 1 A Immunoglobulin heavy chain antibody variable domain D3-L11 9838
550 5JOP 1 D, L Fab 14.22 light chain 10090
551 5JOP 2 E, H Fab14.22 heavy chain 10090
552 1U0Q 1 A, B immunoglobulin heavy chain variable domain 9844
553 4HPO 1 H CH58 Fab heavy chain 9606
554 4HPO 2 L CH58 Fab light chain 9606
555 6FUP 1 A Human F11 T-cell Receptor alpha Chain 9606
556 6FUP 2 B Huamn F11 T-Cell Receptor beta chain 9606
557 5UKN 1 H DH522UCA Fab fragment heavy chain 9544
558 5UKN 2 L DH522UCA Fab fragment light chain 9544
559 4AIZ 1 A, C, D V2-17 PROTEIN 9606
560 4AIZ 2 B V2-17 PROTEIN 9606
561 6BHZ 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
562 6BHZ 2 L, M Trastuzumab Anti-HER2 Fab Light Chain D185A 9606
563 5L21 2 B VHH-C2 30538
564 5IT2 1 H heavy chain 9606
565 5IT2 2 L light chain 9606
566 5JIH 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
567 4POZ 1 C light chain of Fab fragment of 10B9 antibody 10090
568 4POZ 2 D heavy chain of Fab fragment of 10B9 antibody 10090
569 4F57 1 L Light chain of Fab of a neutralizing antibody L1 light chain of L1 9606
570 4F57 2 H Heavy chain of Fab of a neutralizing antibody L1 heavy chain of L1 9606
571 2W59 1 A, B IGY FCU3-4 9031
572 5FWO 1 A NANOBODY 9844
573 2V9T 1 A ROUNDABOUT HOMOLOG 1 IG1-2M, RESIDUES 61-166 9606
574 5KVE 2 L ZV-48 Antibody scFv Light Chain 10090
575 5KVE 3 H ZV-48 Antibody scFv Heavy chain 10090
576 1L6X 1 A IMMUNOGLOBULIN GAMMA-1 HEAVY CHAIN CONSTANT REGION Fc Fragment, Residues 119-325 9606
577 4L1H 1 A Ig kappa chain V-I region Rei 9606
578 5MO3 2 H Fab of monoclonal antibody, heavy chain 10090
579 5MO3 3 L Fab of monoclonal antibody, light chain 10090
580 1OL0 1 A, B IMMUNOGLOBULIN G VARIABLE HEAVY DOMAIN 9606
581 5GZ0 1 A, C FM329 light chain 1383439
582 5GZ0 2 B, D FM329 heavy chain 1383439
583 6DW2 1 A 6078 Fab light chain 9606
584 6DW2 2 B 6078 Fab heavy chain 9606
585 3B9V 1 A, B, C, D heavy chain variable domain 9606
586 4W2P 1 A, B, C, D Anti-Marburgvirus Nucleoprotein Single Domain Antibody C 9844
587 1VFA 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
588 1VFA 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
589 6BQB 1 L MGG4 Fab light chain 9606
590 6BQB 2 H MGG4 Fab heavy chain 9606
591 4PUB 1 H DX-2930 HEAVY CHAIN 9606
592 4PUB 2 L DX-2930 LIGHT CHAIN 9606
593 6B14 1 H Heavy chain of Fab BL3-6S97N 10090
594 6B14 2 L Light chain of Fab BL3-6S97N 10090
595 5N88 1 A, H VH59 antibody 9606
596 5DD6 1 A, H ANTI-HIV ANTIBODY DH570.mut58 FAB HEAVY CHAIN 9544
597 5DD6 2 B, L ANTI-HIV ANTIBODY DH570.mut58 FAB LIGHT CHAIN 9544
598 5TEZ 4 I TCR F50 alpha chain 9606
599 5TEZ 5 J TCR F50 beta chain 9606
600 2D7T 1 H anti polyhydroxybutyrate antibody Fv, heavy chain residues 1-133 9606
601 2D7T 2 L anti polyhydroxybutyrate antibody Fv, light chain residues 1-110 9606
602 3WIH 2 L, M anti-human ROBO1 antibody B2212A Fab light chain 10090
603 3WIH 3 H, I anti-human ROBO1 antibody B2212A Fab heavy chain 10090
604 5GS3 1 A, H diabody protein 9606
605 3BD3 1 A, B catalytic antibody 10090
606 4DZB 1 A Valpha7.2-Jalpha33 (MAIT T cell receptor) 9606
607 4DZB 2 B Vbeta2 (MAIT T cell receptor) 9606
608 2OTU 1 A, C, E, G Fv light chain variable domain 10090
609 2OTU 2 B, D, F, H Fv heavy chain variable domain 10090
610 3CFC 1 H BLUE FLUORESCENT ANTIBODY EP2-19G2-IGG2B HEAVY CHAIN FAB 10090
611 3CFC 2 L BLUE FLUORESCENT ANTIBODY EP2-19G2-KAPPA LIGHT CHAIN FAB 10090
612 6APP 1 A Anti-Marburgvirus Nucleoprotein Single Domain Antibody A 9844
613 3V4U 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
614 3V4U 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
615 5VKD 2 H Fab Heavy Chain 9606
616 5VKD 3 L Fab light chain 9606
617 2R1Y 1 A Fab, antibody fragment (IgG1k), light chain 10090
618 2R1Y 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
619 1EFQ 1 A KAPPA-4 IMMUNOGLOBULIN (LIGHT CHAIN) 9606
620 5XHG 1 A, C polypeptide(L) 10090
621 5XHG 2 B, D polypeptide(H) 10090
622 4XMP 2 H HEAVY CHAIN OF ANTIBODY VRC08 9606
623 4XMP 3 L LIGHT CHAIN OF ANTIBODY VRC08 9606
624 5L8J 2 B New antigen receptor variable domain 168098
625 3UYR 1 H antibody Fab heavy chain 10090
626 3UYR 2 L antibody Fab light chain 10090
627 3V0W 1 L WN1 222-5 Fab (IgG2a) light chain 10090
628 3V0W 2 H WN1 222-5 Fab (IgG2a) heavy chain 10090
629 5OCX 1 L Fab fragment anti-citrullinated protein antibody E4 - light chain N-terminal glutamine is posttranslationally modified to pyroglutamic acid produced as chimera of human E4 mAb variable domains and mouse IgG2a constant domains 9606
630 5OCX 2 H Fab fragment of anti-citrullinated protein antibody E4 - heavy chain unmodelled residues not visible in electron density produced as chimera of human mAb E4 variable domains and mouse IgG2a constant domains 9606
631 1YQV 1 L HyHEL-5 Antibody Light Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
632 1YQV 2 H HyHEL-5 Antibody Heavy Chain IG*G1 FAB FRAGMENT (HY/HEL-5) 10090
633 3OAZ 1 H, M Fab 2G12, heavy chain Fab 9606
634 3OAZ 2 K, L Fab 2G12, light chain 9606
635 2R2B 1 A Fab, antibody fragment (IgG1k), light chain 10090
636 2R2B 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
637 1T6V 2 N, O novel antigen receptor 7801
638 1ZAN 1 L Fab AD11 Light Chain 10116
639 1ZAN 2 H Fab AD11 Heavy Chain 10116
640 4BSV 1 A HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
641 4BSV 2 B HETERODIMERIC FC ANTIBODY AZYMETRIC VARIANT 2 IG GAMMA 1 FC DOMAIN, RESIDUES 106-330 9606
642 6CJK 1 A, C Immunoglobulin Fab light chain 9986
643 6CJK 2 B, D Immunoglobulin Fab heavy chain 9986
644 4N0Y 1 H IGH526 Heavy Chain 9606
645 4N0Y 2 L IGH526 Light Chain 9606
646 3V52 1 H ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 H CHAIN 10090
647 3V52 2 L ANTI-MHC-I MONOCLONAL ANTIBODY, 64-3-7 L CHAIN 10090
648 5MTH 1 A, H antibody Fab heavy chain 10090
649 5MTH 2 B, L antibody Fab light chain 10090
650 3GGW 1 A, C FAB F22-4 LIGHT CHAIN 10090
651 3GGW 2 B, D FAB F22-4 HEAVY CHAIN 10090
652 2E27 1 L anti-ciguatoxin antibody, light chain Fv fragment 10090
653 2E27 2 H anti-ciguatoxin antibody, heavy chain Fv fragment 10090
654 1BEC 1 A 14.3.D T CELL ANTIGEN RECEPTOR 10090
655 1RZF 1 L Fab E51 light chain 9606
656 1RZF 2 H Fab E51 heavy chain 9606
657 4N1C 1 A, B immunoglobulin variable light chain domain 9606
658 4KTE 1 H GE148 Heavy Chain Fab Fab fragment 9544
659 4KTE 2 L GE148 Light Chain Fab 9544
660 5I8O 1 H HMM5 antibody heavy chain 9606
661 5I8O 2 L HMM5 antibody light chain 9606
662 4OUO 1 A anti Bla g 1 scFv 9031
663 4JG0 1 L Fab light chain 9606
664 4JG0 2 H Fab heavy chain 9606
665 4YGV 1 A, F aDabi-Fab2a heavy chain 9606
666 4YGV 2 B, L aDabi-Fab2a light chain 9606
667 5JDJ 1 A, B, C, D, E, F, G, H, I, J, K, L, M, N, O, P Titin 9606 2.7.11.1 | Details
668 5U4R 1 A, H VRC 315 53-1A09 Fab Heavy chain 9606
669 5U4R 2 B, L VRC 315 53-1A09 Fab Light chain 9606
670 5ALC 1 H ANTI-TICAGRELOR FAB 72, HEAVY CHAIN 9606
671 5ALC 2 L ANTI-TICAGRELOR FAB 72, LIGHT CHAIN 9606
672 5U5F 1 A MEMAB TRASTUZUMAB FAB LIGHT CHAIN I83E 9606
673 5U5F 2 B MEMAB TRASTUZUMAB FAB HEAVY CHAIN 9606
674 3EO0 1 A, C GC-1008 Fab Light Chain 10090
675 3EO0 2 B, D GC-1008 Fab Heavy Chain 10090
676 5CIL 1 H FAB 4E10 HEAVY CHAIN 9606
677 5CIL 2 L FAB 4E10 LIGHT CHAIN 9606
678 6BI2 1 H, I Trastuzumab Anti-HER2 Fab Heavy Chain 9606
679 6BI2 2 L, M Trastuzumab Anti-HER2 Fab Light Chain 9606
680 5F3B 1 A, E RK35 Chimeric antibody heavy chain 10090
681 5F3B 2 B, F RK35 Chimeric antibody light chain 10090
682 6FUR 1 A, C Human F11 T-Cell Receptor alpha chain 9606
683 6FUR 2 B, D Human F11 T-Cell Receptor 9606
684 4POU 2 B VHH Antibody 9844
685 3B5T 1 A, B, C, D, E Novel immune-type receptor 10 Extracellular fragment 7998
686 1MVF 1 A, B immunoglobulin heavy chain variable region 9838
687 4FQI 3 H antibody CR9114 heavy chain Fab 9606
688 4FQI 4 L antibody CR9114 light chain Fab Lambda 9606
689 4JVP 1 A, B Anti-HCV E2 alpaca nanobody D03 30538
690 6FUM 1 A Human F11 T-Cell Receptor alpha chain 9606
691 6FUM 2 B Human F11 T-Cell Receptor beta chain 9606
692 3QSK 2 B Engineered 5 Histidine anti-RNase A Camelid VHH Antibody Domain Variant 9838
693 4AIX 1 A, B, C, D IG LAMBDA CHAIN V-IV REGION BAU 9606
694 4JHA 1 H D25 antigen-binding fragment heavy chain 9606
695 4JHA 2 L D25 light chain 9606
696 6B9Z 1 A Trastuzumab Fab light chain 10090
697 6B9Z 2 B Trastuzumab Fab heavy chain CSO is partially oxidized cysteine 10090
698 3MCL 1 L C706 MONOCLONAL LIGHT CHAIN CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
699 3MCL 2 H C706 MONOCLONAL HEAVY CHAIN FD fragment of the heavy chain, CHIMERIC MOLECULE OF MOUSE VARIABLE DOMAIN AND HUMAN CONSTANT DOMAIN 10090
700 4PTT 1 A Antibody pn132p2C05, light chain 9606
701 4PTT 2 B Antibody pn132p2C05, heavy chain 9606
702 5OD0 1 L Fab fragment of ACPA E4 - Light chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid 2 C-terminal residues not visible in electron density and therefore not modelled 9606
703 5OD0 2 H Fab fragment of ACPA E4 - heavy chain the Fab fragment was prepared from a chimeric antibody containing the variable domain of human ACPA E4 and constant domains of mouse IgG2b the N-terminal Gln is posttranslationally modified to pyroglutamic acid residues not modeled are not visible in the electron density map 9606
704 4EJ1 2 C, D Nb113 camelid antibody fragment 9844
705 5KVL 1 H Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) heavy chain Fab fragment 9606
706 5KVL 2 L Humanized 10G4 anti-Leukotriene C4 Immunoglobulin G (IgG) light chain 9606
707 5TDO 1 A, C anti-HER2 Fab Light Chain 9606
708 5TDO 2 B, D anti-HER2 Fab Heavy Chain 9606
709 2P42 2 B, D ANTIBODY CAB-RN05 9838
710 8FAB 1 A, C IGG1-LAMBDA HIL FAB (LIGHT CHAIN) 9606
711 8FAB 2 B, D IGG1-LAMBDA HIL FAB (HEAVY CHAIN) 9606
712 6CPH 1 D TCR alpha chain 9606
713 6CPH 2 E TCR beta chain 9606
714 5NHW 1 H anti-human ActRII Bimagrumab Fab heavy-chain C-terminal FLAG-His6 tag Fab heavy-chain 9606
715 5NHW 2 L anti-human ActRII Bimagrumab Fab light-chain Fab light-chain 9606
716 5M02 3 G Protein Trav14-1,T-cell receptor alpha chain C region 10090
717 5M02 4 H T-cell receptor beta chain V region C5,T-cell receptor beta-2 chain C region 10090
718 2ZPK 1 L, M IgG1-lambda P20.1 Fab (light chain) 10090
719 2ZPK 2 H, I IgG1-lambda P20.1 Fab (heavy chain) Variable and Constant region 10090
720 4DGV 1 H HCV1 Heavy Chain Fab 9606
721 4DGV 2 L HCV1 Light Chain 9606
722 2JJV 1 A, B SIGNAL-REGULATORY PROTEIN BETA 1. 2 ISOFORMS PRODUCED BY ALTERNATIVE SPLICING. IN THIS ENTRY ISOFORM 1 (O00241-1) IS PRESENT N-TERMINAL ECTODOMAIN, RESIDUES 30-148 9606
723 2DQU 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
724 2DQU 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
725 5TH2 1 A, C cetuximab Fab, light chain 10090
726 5TH2 2 B, D cetuximab Fab, heavy chain 10090
727 4W4O 1 A, B Ig gamma-1 chain C region UNP residues 107-330 9606
728 1I8K 1 A EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV LIGHT CHAIN 10090
729 1I8K 2 B EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY MR1SCFV HEAVY CHAIN 10090
730 5I8K 1 L HHH1 Fab Light chain 9606
731 5I8K 2 H HHH1 Fab Heavy chain 9606
732 4QLR 1 A, B Llama nanobody n02 VH domain 9844
733 5J56 2 B VHH single chain antibody V1C7 30538
734 4YDL 2 B, H HEAVY CHAIN OF ANTIBODY C38-VRC18.02 9606
735 4YDL 3 C, L LIGHT CHAIN OF ANTIBODY C38-VRC18.02 9606
736 3T4Y 1 A S25-2 FAB (IGG1K) LIGHT CHAIN 10090
737 3T4Y 2 B S25-2 FAB (IGG1K) HEAVY CHAIN 10090
738 1YNL 1 L Ig gamma light chain 10090
739 1YNL 2 H Ig gamma heavy chain 10090
740 5EPM 1 A, E Antibody Fab fragment heavy chain 10090
741 5EPM 2 B, F Antibody Fab fragment light chain 10090
742 2AJS 1 L Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 kappa light chain 10090
743 2AJS 2 H Antibody 7A1 FAB' IMMUNOGLOBULIN IGG1 HEAVY CHAIN 10090
744 5VH5 1 A Infliximab Fc 10090
745 3UMT 1 A scFv heavy chain and light chain 10090
746 3BZ4 1 A, C, E, G Fab F22-4 light chain 10090
747 3BZ4 2 B, D, F, H Fab F22-4 heavy chain 10090
748 4NUJ 1 A PGT152 light chain 9606
749 4NUJ 2 B PGT152 heavy chain 9606
750 3LIZ 2 L 4C3 monoclonal antibody Light Chain 10090
751 3LIZ 3 H 4C3 monoclonal antibody Heavy Chain 10090
752 1RUA 1 L immunoglobulin igg2a, light chain fab 10090
753 1RUA 2 H immunoglobulin igg2a, heavy chain fab 10090
754 3U2S 1 A, H PG9 heavy chain antigen-binding fragment 9606
755 3U2S 2 B, L PG9 light chain 9606
756 4X4Z 1 A, B Herceptin VL domain with F53D mutation 9606
757 3NOI 1 A, B Natural cytotoxicity triggering receptor 3 Extracellular domain (unp residues 18-130) 9606
758 5D6C 1 A, L 4497 antibody IgK (VL and CL) 9606
759 5D6C 2 B, H 4497 antibody IgG1 (VH and CH1) 9606
760 4GAG 1 H NEUTRALIZING ANTIBODY AP33 HEAVY CHAIN 10090
761 4GAG 2 L NEUTRALIZING ANTIBODY AP33 LIGHT CHAIN 10090
762 2R23 1 A Fab, antibody fragment (IgG1k), light chain 10090
763 2R23 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
764 5JII 1 A, B Ig gamma-1 chain C region Hinge-CH2-CH3, UNP Residues 108-329 9606
765 4NUG 1 L PGT151 light chain 9606
766 4NUG 2 H PGT151 heavy chain 9606
767 3IU4 1 H chP3 Fab heavy chain 10090
768 3IU4 2 L chP3 Fab light chain 10090
769 3MNZ 2 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN mouse Fv,human Fc 10090
770 3MNZ 3 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN mouse Fv,human Fc 10090
771 3MLR 1 L Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab light chain 9606
772 3MLR 2 H Human monoclonal anti-HIV-1 gp120 V3 antibody 2557 Fab heavy chain 9606
773 1QYG 1 L FAB M82G2, LIGHT CHAIN 10090
774 1QYG 2 H FAB M82G2, HEAVY CHAIN 10090
775 1P7K 1 A, L antibody light chain FAB 10090
776 1P7K 2 B, H antibody heavy chain FAB 10090
777 4NBX 2 B A20.1 VHH 9844
778 1G7J 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
779 1G7J 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
780 3RVV 2 C 4C1 - light chain 10090
781 3RVV 3 D 4C1 - heavy chain 10090
782 4HEP 2 G vHH17 domain 9844
783 5A2L 1 H SCFV-SM3 RESIDUES 6-115,20-129 10090
784 3P0Y 2 H Fab DL11 heavy chain 9606
785 3P0Y 3 L Fab DL11 light chain 9606
786 4NPY 1 A, L germline PGT121 light chain Fab 9606
787 4NPY 2 B, H germline PGT121 heavy chain Fab 9606
788 6ANA 2 H LL2 Fab Heavy Chain 10090
789 6ANA 3 L LL2 Fab Light Chain 10090
790 5IBU 1 B, L 6652 Light Chain 9606
791 5IBU 2 G, H 6652 Heavy Chain 9606
792 6FRA 1 A Human T-Cell Receptor F11 alpha Chain 9606
793 6FRA 2 B Human T-Cell Receptor F11 beta Chain 9606
794 5VPL 2 C 4C1 - LIGHT CHAIN 10090
795 5VPL 3 D 4C1 - HEAVY CHAIN 10090
796 6AOD 1 A FXIa Antibody FAB Light Chain 9606
797 6AOD 2 B FXIa Antibody FAB Heavy Chain 9606
798 5WCD 1 H VRC315 04-1D02 Fab Heavy chain 9606
799 5WCD 2 L VRC315 04-1D02 Fab Light chain 9606
800 2YPV 2 H FAB 12C1 10090
801 2YPV 3 L FAB 12C1 10090
802 3QXU 1 A, B, C, D Anti-Methotrexate CDR1-3 Graft 9844
803 1PEW 1 A, B Jto2, a LAMBDA-6 TYPE IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN IMMUNOGLOBULIN LIGHT CHAIN, VARIABLE DOMAIN 9606
804 5EDX 1 A, B CD8 alpha antigen UNP RESIDUES 2-115 9823
805 4HH9 1 A, C Fab KE5, light chain KE5 Light chain 9606
806 4HH9 2 B, D Fab KE5, heavy chain KE5 Heavy Chain 9606
807 4JY5 1 L PGT122 light chain Fab 9606
808 4JY5 2 H PGT122 heavy chain Fab 9606
809 6ELE 1 A, H fAB heavy chain 9606
810 6ELE 2 B, L fAB light chain 9606
811 2AQ2 1 A T-CELL RECEPTOR BETA CHAIN V 10090
812 1VFB 1 A IGG1-KAPPA D1.3 FV (LIGHT CHAIN) 10090
813 1VFB 2 B IGG1-KAPPA D1.3 FV (HEAVY CHAIN) 10090
814 5UR8 1 A human immunoglobulin gamma, heavy chain Fd fragment 9606
815 5UR8 2 B human immunoglobulin gamma, kappa light chain 9606
816 6B5R 1 H CIS42 Fab Heavy chain 9606
817 6B5R 2 L CIS42 Fab Light chain 9606
818 5IML 2 B Nanobody 9835
819 5W38 1 A, B Immunoglobulin heavy constant gamma 3 Fc domain, UNP residues 155-377 9606 1.1.1 | Details
820 3NAC 1 L Fab15 Mut7 light chain 9606
821 3NAC 2 H Fab15 Mut7 heavy chain 9606
822 3A6C 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
823 3A6C 2 H IG VH, anti-lysozyme 10090
824 2DQD 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
825 2DQD 2 H Ig VH,anti-lysozyme 10090
826 2JJS 1 A, B TYROSINE-PROTEIN PHOSPHATASE NON-RECEPTOR TYPE SUBSTRATE 1 N-TERMINAL ECTODOMAIN, RESIDUES 31-148 9606
827 1HCV 1 A IMMUNOGLOBULIN G FROM IMMUNIZED LLAMA HEAVY CHAIN VARIABLE DOMAIN FROM LLAMA 9844
828 1WTL 1 A, B BENCE-JONES PROTEIN MCG (LIGHT CHAIN) 9606
829 2I25 1 N, O New Antigen Receptor PBLA8 variable domain 7801
830 5U5M 1 A MEMAB TRASTUZUMAB, LIGHT CHAIN 9606
831 5U5M 2 B MEMAB TRASTUZUMAB, HEAVY CHAIN 9606
832 2DQT 1 L IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
833 2DQT 2 H IMMUNOGLOBULIN 6D9 FAB FRAGMENT 10090
834 1Q72 1 L Fab M82G2, Light chain 10090
835 1Q72 2 H Fab M82G2, Heavy chain 10090
836 4M1D 1 L, M Fab mAb 447-52D Light Chain 9606
837 4M1D 2 H, I Fab mAb 447-52D Heavy Chain 9606
838 1SEQ 1 L Monoclonal Antibody MNAC13 FAB Light Chain 10090
839 1SEQ 2 H Monoclonal Antibody MNAC13 FAB Heavy Chain 10090
840 1G7I 1 A ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 LIGHT CHAIN 10090
841 1G7I 2 B ANTI-HEN EGG WHITE LYSOZYME MONOCLONAL ANTIBODY D1.3 HEAVY CHAIN 10090
842 4YHO 1 H aDabi-Fab3 heavy chain 9606
843 4YHO 2 L aDabi-Fab3 light chain 9606
844 2WWK 1 O OBSCURIN-LIKE PROTEIN 1 IG1, RESIDUES 1-106 9606
845 2WWK 2 T TITIN M10, RESIDUES 34252-34350 9606 2.7.11.1 | Details
846 2R1W 1 A Fab, antibody fragment (IgG1k), light chain 10090
847 2R1W 2 B Fab, antibody fragment (IgG1k), heavy chain 10090
848 3MO1 1 A ANTI-HIV-1 ANTIBODY 13H11 LIGHT CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
849 3MO1 2 B ANTI-HIV-1 ANTIBODY 13H11 HEAVY CHAIN FUSION PROTEIN between mouse Fv and a human Fc 10090
850 4DGY 1 H HCV1 Heavy Chain Fab 9606
851 4DGY 2 L HCV1 Light Chain 9606
852 3A67 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
853 3A67 2 H IG VH, anti-lysozyme 10090
854 2APB 1 A T-cell receptor beta chain V 10116
855 2APX 1 A T cell receptor beta chain V 10116
856 1RI8 1 A camelid ANTIBODY HEAVY CHAIN VHH domain, VARIABLE DOMAIN 9838
857 6EH6 1 A Human T Cell Receptor Alpha Chain 9606
858 6EH6 2 B Human T Cell Receptor BetaChain 9606
859 5EN2 1 A GD01 heavy chain 10090
860 5EN2 2 B GD01 light chain 10090
861 3T77 1 A S25-2 FAB (IGG1K) light chain 10090
862 3T77 2 B S25-2 FAB (IGG1K) heavy chain 10090
863 1J1X 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
864 1J1X 2 H Ig VH,anti-lysozyme 10090
865 5L8K 2 B New antigen receptor variable domain 168098
866 5M2J 2 D Anti-(ED-B) scFV 9606
867 3MXW 2 L 5E1 light chain 9606
868 3MXW 3 H 5E1 heavy chain 9606
869 2V7N 1 A, C, E, G IMMUNOGLOBULIN LIGHT CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-255 32630
870 2V7N 2 B, D, F, H IMMUNOGLOBULIN HEAVY CHAIN SYNTHETIC GENE, DERIVED FROM PHAGE DISPLAY OF THE HUMAN COMBINATORIAL ANTIBODY LIBRARY (HUCAL) FAB FRAGMENT, RESIDUES 1-259 32630
871 2DQC 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
872 2DQC 2 H Ig VH,anti-lysozyme 10090
873 1J1O 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
874 1J1O 2 H Ig VH,anti-lysozyme 10090
875 1TVD 1 A, B T CELL RECEPTOR DELTA CHAIN, VARIABLE DOMAIN 9606
876 3EO9 1 L Efalizumab Fab fragment, light chain 9606
877 3EO9 2 H Efalizumab Fab fragment, heavy chain 9606
878 1MVU 1 A Ig kappa-chain VJ-region (Light chain) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
879 1MVU 2 B Ig VDJ-region (HEAVY CHAIN) LIGHT AND HEAVY CHAINS LINKED WITH A SYNTHETIC (GGGGS)3 LINKER 10090
880 4M62 1 L, M GEP2 FV light chain UNP residues 21-129 9606
881 4M62 2 H, I GEP2 FV heavy chain 9606
882 4ALA 2 H FAB 2H12 HEAVY CHAIN 10090
883 4ALA 3 L FAB 2H12 LIGHT CHAIN 10090
884 5IVO 1 A BC2-nanobody 30538
885 1J1P 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
886 1J1P 2 H Ig VH,anti-lysozyme 10090
887 4F33 1 A, C, E, G MORAb-009 FAB light chain 10090
888 4F33 2 B, D, F, H MORAb-009 FAB heavy chain 10090
889 4NBZ 2 B, D A26.8 VHH 9844
890 3C6S 1 A, C, E, G Fab F22-4 light chain 10090
891 3C6S 2 B, D, F, H Fab F22-4 heavy chain 10090
892 5WUV 1 L light chain 9606
893 5WUV 2 H heavy chain 9606
894 1QAC 1 A, B IMMUNOGLOBULIN LIGHT CHAIN VARIABLE DOMAIN VARIABLE DOMAIN 9606
895 4Z8F 1 H S1-15 Fab (IgG2b) heavy chain 10090
896 4Z8F 2 L S1-15 Fab (IgG2b kappa) light chain 10090
897 3OKL 1 A S25-39 Fab (IgG1k) light chain 10090
898 3OKL 2 B S25-39 Fab (IgG1k) heavy chain 10090
899 2BNQ 4 D T-CELL RECEPTOR ALPHA CHAIN V REGION CONTAINS ALSO C (CONSTANT) REGION 9606
900 2BNQ 5 E T-CELL RECEPTOR BETA CHAIN C REGION EXTRACELLULAR, RESIDUES 1-130 9606
901 5AYU 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
902 5AYU 2 H Ig VH,anti-lysozyme 10090
903 4JM4 1 H PGT 135 Heavy Chain Fab 9606
904 4JM4 2 L PGT 135 Light Chain Fab 9606
905 2HWZ 1 L Immunoglobulin Fab light chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
906 2HWZ 2 H Immunoglobulin Fab heavy chain Humanized mouse antibody MEDI-493 Anti-respiratory syncytial virus antibody 10090
907 3A6B 1 L Lysozyme binding ig kappa chain V23-J2 region 10090
908 3A6B 2 H IG VH, anti-lysozyme 10090
909 2DQJ 1 L lysozyme binding Ig kappa chain V23-J2 region 10090
910 2DQJ 2 H Ig VH,anti-lysozyme 10090
911 5YE4 1 A, C 1A9D7 VH CH1 chain 10090
912 5YE4 2 B, D 1A9D7 L chain 10090
913 5F21 2 B nanobody MU375 9844
914 1N4X 1 L, M immunoglobulin kappa chain variable region 10090
915 1N4X 2 H, I immunoglobulin heavy chain variable region 10090
916 6B0G 1 C 1245 Antibody, Light Chain 9606
917 6B0G 2 D 1245 Antibody, Heavy Chain 9606
918 5TDP 1 A, C anti-HER2 Fab Light Chain 9606
919 5TDP 2 B, D anti-HER2 Fab Heavy Chain 9606
920 1ZEA 1 L monoclonal anti-cholera toxin IGG1 KAPPA antibody, L chain 10090
921 1ZEA 2 H monoclonal anti-cholera toxin IGG1 KAPPA antibody, H chain 10090
922 6BAH 1 A Trastuzumab Fab light chain,Immunoglobulin kappa constant 10090
923 6BAH 2 B Trastuzumab Fab heavy chain,IGH@ protein 10090
924 4WNQ 1 A, C TCR Variable Delta 1 chain and TCR constant Alpha chain 9606
925 4WNQ 2 B, D TCR Variable Beta 2 (TRBV20) chain and TCR constant Beta chain 9606
926 6D0X 1 A 2140 Antibody, heavy chain 9606
927 6D0X 2 B 1210 Antibody, light chain 9606
928 2Q86 1 A, C Valpha14 TCR extracellular domain 10090
929 2Q86 2 B, D Vbeta8.2 extracellular domain 10090
930 2P44 2 B ANTIBODY CAB-RN05 9838
931 6BE4 1 H Fab (F598) Heavy Chain 9606
932 6BE4 2 L Fab(F598) Light Chain 9606
933 6FRB 1 A Human T-Cell Receptor F11 alpha chain 9606
934 6FRB 2 B Human T-Cell Receptor F11 beta Chain 9606
935 3DVF 1 A Amyloidogenic immunoglobulin light chain protein AL-12 9606
936 5TPP 1 L DH270.5 Fab heavy chain 9606
937 5TPP 2 H DH270.5 Fab light chain 9606